| 000 | 01515 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516182936.0 | ||
| 264 | 0 | _c20140123 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1538-5159 | ||
| 024 | 7 |
_a10.1097/HP.0b013e3182a4dd2c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarese, Ann M | |
| 245 | 0 | 0 |
_aThe ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependent. _h[electronic resource] |
| 260 |
_bHealth physics _cJan 2014 |
||
| 300 |
_a39-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 | _aFilgrastim |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xpharmacology |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aWhole-Body Irradiation _xadverse effects |
| 700 | 1 | _aBrown, Cassandra R | |
| 700 | 1 | _aSmith, Cassandra P | |
| 700 | 1 | _aGibbs, Allison M | |
| 700 | 1 | _aKatz, Barry P | |
| 700 | 1 | _aJohnson, Cynthia S | |
| 700 | 1 | _aPrado, Karl L | |
| 700 | 1 | _aMacVittie, Thomas J | |
| 773 | 0 |
_tHealth physics _gvol. 106 _gno. 1 _gp. 39-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/HP.0b013e3182a4dd2c _zAvailable from publisher's website |
| 999 |
_c23308356 _d23308356 |
||